-
Mashup Score: 1Exploring Cabozantinib Plus Nivolumab: A Breakthrough in Advanced Angiosarcoma - An Interview with Dr. Gary Schwartz - 10 month(s) ago
In this enlightening interview, esteemed Oncologist Dr. Gary Schwartz discusses the promising development and potential of Cabozantinib plus Nivolumab as a therapeutic approach in advanced Angiosarcoma. Drawing from his extensive experience and recent clinical trials, Dr. Schwartz delves into the efficacy and safety…
Source: oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial - PubMed - 12 month(s) ago
ClinicalTrials.gov Identifier: NCT02979899.
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 6Regeneration after rare head and neck cancer - Mayo Clinic Comprehensive Cancer Center Blog - 1 year(s) ago
The story of Alison O’Neill’s diagnosis of angiosarcoma, a rare cancer of the blood vessels, and her road to recovery with the help of regenerative medicine.
Categories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 6Valley woman has deadly blemish removed at Mayo Clinic - 1 year(s) ago
Allison O’Neill has a zest for life that is immediately noticed when you meet her. For five years that zest has been minimized after noticing a small bump on her right cheek.
Source: ABC15 Arizona in Phoenix (KNXV)Categories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 1
Drs. Lene Veiga and Amy Berrington in the Radiation Epidemiology Branch explored the risk of thoracic soft tissue sarcomas among breast cancer survivors in two U.S. cohorts. They identified a history of hypertension or diabetes as novel potential co-factors for radiation-induced angiosarcoma.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0A mouse model for Li-Fraumeni-Like Syndrome with cardiac angiosarcomas associated to POT1 mutations - 1 year(s) ago
Author summary We have generated a mouse model for the human POT1R117C mutation found in Li-Fraumeni-Like (LFL) families with cases of cardiac angiosarcoma by introducing this mutation in the Pot1a endogenous locus, knock-in for Pot1aR117C. The Pot1a+/ki mice show longer telomeres than wild-type controls. Longer telomeres in mutant mice are dependent on telomerase activity as they are not found…
Source: journals.plos.orgCategories: Genetics, Latest HeadlinesTweet
-
Mashup Score: 3Angiosarcoma survivor aspires to become an oncologist - 2 year(s) ago
When Michael Scott underwent treatment for angiosarcoma in college, he was inspired by his MD Anderson care team. Today, he’s in medical school and working to become an oncologist.
Source: MD Anderson Cancer CenterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4
https://youtu.be/yRFSwRcFDW4 Alison O’Neill’s love for life is as infectious as her grateful attitude. Alison O’Neill
Categories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0Angiosarcoma survivor aspires to become an oncologist - 2 year(s) ago
When Michael Scott underwent treatment for angiosarcoma in college, he was inspired by his MD Anderson care team. Today, he’s in medical school and working to become an oncologist.
Source: MD Anderson Cancer CenterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0No PFS Benefit With Carotuximab in Advanced Angiosarcoma - 2 year(s) ago
Researchers compared carotuximab plus pazopanib with pazopanib alone in patients with advanced angiosarcoma.
Source: Oncology Nurse AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
📣 ASCO 2023 🩺💼 👉 OncologyTube interview featuring #GarySchwartzMD 👨⚕️🎥 🌟 Discover the latest advancements in oncology with the combination therapy of Cabozantinib plus Nivolumab! 💪🔬 🔗 https://t.co/ENmuMerS9h @CleClinicMD #Cabozantinib #Angiosarcoma #ASCO23 https://t.co/dIJxqxRRys